Updates are available Correction dated 2024-12-16
Click to view Correction: https://doi.org/10.1007/s40259-024-00695-w
-
Authors
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (R35GM136300)
National Institute on Aging (R01AG080016)
National Institute of Neurological Disorders and Stroke (R21NS132018)
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (R21AI171844)
- License Information
-
More Information
Article History
Accepted: 4 June 2024
First Online: 2 July 2024
Change Date: 16 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40259-024-00695-w
Declarations
:
: J.S.S, N.S.S., and P.M.T. contributed to the writing of this article. All authors read and approved the final manuscript.
: This work was supported by the National Institutes of Health (R35GM136300, R01AG080016, R21NS132018 and R21AI171844 to P.M.T., and F32GM137513 to J.S.S.), and the Albert M. Mattocks Chair (to P.M.T.).
: J.S.S. is an employee of AstraZeneca and P.M.T. is a member of the scientific advisory boards for Nabla Bio, Aureka Biotechnologies, and Dualitas Therapeutics. The other author declares no competing interests, financial or non-financial interests or affiliations with any organization or entity with financial or nonfinancial interest in the materials discussed in the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
